Sildenafil citrate

CAS No. 171599-83-0

Sildenafil citrate ( Apodefil; Tonafil; UK 92480 )

Catalog No. M12615 CAS No. 171599-83-0

Sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 30 In Stock
50MG 41 In Stock
100MG 52 In Stock
200MG 87 In Stock
500MG 178 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sildenafil citrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).
  • Description
    Sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5), is a well-tolerated and highly effective treatment for erectile dysfunction.
  • Synonyms
    Apodefil; Tonafil; UK 92480
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE5; PDE6
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    171599-83-0
  • Formula Weight
    666.70
  • Molecular Formula
    C28H38N6O11S
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 20 mg/mL warmed (29.99 mM)
  • SMILES
    OC(=O)CC(O)(CC(O)=O)C(O)=O.CCCC1=NN(C)C2=C1NC(=NC2=O)C1=C(OCC)C=CC(=C1)S(=O)(=O)N1CCN(C)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nehra A, et al. World J Urol, 2001, 19(1), 40-45.
molnova catalog
related products
  • D 159687

    D159687 is a selective?PDE4D?inhibitorhad a procognitive profile as it improved memory in the novel object recognition test but had no antidepressant or anxiolytic benefit.

  • Filaminast

    Filaminast (WAY-PDA-641;PDA-641;WAY-123641) is a potent and selective PDE4 inhibitor with IC50 of 420 nM, displays 36-fold selectivity over PDE3.

  • Siguazodan

    Siguazodan is an effective, selective, orally active phosphodiesterase III ((PDE-III)) inhibitor with an IC50 of 117 nM.